Elisa Pucu
elisapucu.bsky.social
Elisa Pucu
@elisapucu.bsky.social
Parasitologist 🔬🦠, Senior editor @The Lancet Microbe, Views my own
Reposted by Elisa Pucu
New Research

Immunogenicity and safety of a dose-sparing inactivated poliovirus vaccine in infants in India: a phase 2/3, double-blind, randomised controlled trial

www.thelancet.com/journals/lan...
Immunogenicity and safety of a dose-sparing inactivated poliovirus vaccine in infants in India: a phase 2/3, double-blind, randomised controlled trial
ds-IPV was immunologically non-inferior to IPV and had a similar safety profile. The new adjuvanted IPV could become an alternative option to IPV. The availability of ds-IPV will support a constant su...
www.thelancet.com
May 18, 2026 at 6:56 AM
Reposted by Elisa Pucu
New joint series in @lancetgh.bsky.social and The Lancet Microbe

#Schistosomiasis in women and adolescent girls

www.thelancet.com/series-do/sc...

#IDSky #ClinMicro #NTD #OpenAccess #OA
May 14, 2026 at 7:48 AM
Reposted by Elisa Pucu
In advance of our September issue, our latest editorial is now online.

#Blastocystis: the ongoing parasitological debate

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #OpenAccess #OA
August 29, 2025 at 1:52 PM
Reposted by Elisa Pucu
Our September issue is now online:

www.thelancet.com/journals/lan...

Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #SARS-CoV-2 #HIV #Pneumocystis #tuberculosis #TB #gonorrhoea #Citrobacter #AMR #Salmonella

#IDSky #ClinMicro #OA
September 9, 2025 at 8:35 AM